Singh, 2010 - Google Patents
Coreceptor utilization and primary cell tropism by HIV-1 subtype C strains.Singh, 2010
- Document ID
- 197981674061929133
- Author
- Singh A
- Publication year
External Links
- 241000713772 Human immunodeficiency virus 1 0 title abstract description 135
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse Transcribing RNA Viruses
- C12N2740/00011—Reverse Transcribing RNA Viruses
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ndung'u et al. | HIV-1 subtype C in vitro growth and coreceptor utilization | |
| Svicher et al. | HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro | |
| Coetzer et al. | Evolution of CCR5 use before and during coreceptor switching | |
| Aasa-Chapman et al. | Primary CCR5 only using HIV-1 isolates does not accurately represent the in vivo replicating quasi-species | |
| Singh | Coreceptor utilization and primary cell tropism by HIV-1 subtype C strains. | |
| Singh et al. | Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolates | |
| Singh | Acquired and transmitted drug resistance in HIV-1 subtype C: implications of novel mutations on replication capacity, cleavage and drug susceptibility. | |
| Mphahlele | In vitro selection and characterisation of human immunodeficiency virus type-1 subtype C integrase strand transfer inhibitor resistant mutants | |
| Caucci | Replicative capacity and phenotypic sensitivity to antiretroviral compounds of HIV-1 strains from recently infected and chronically treated patients | |
| Diallo | The viral diversity in the EPIC4 cohort and the evolution of the size of the HIV-1 cellular reservoir in perinatally infected children and adolescents under cART | |
| Ferreira | New Insights Into the Nature of the HIV-2 Reservoir | |
| de Araujo Ferreira | New Insights into the Nature of the HIV-2 Reservoir | |
| Borm | Envelope glycoprotein determinants of HIV-1 in ART-naïve subjects with progressive HIV-1 subtype C infection | |
| McInally | Effects of systemic biomarkers on HIV-1 acquisition and subtype A and C infections | |
| Gartner | Elucidating the mechanisms of HIV viral reservoir establishment and maintenance | |
| Connell | In vitro selection of CD4-independent HIV-1 subtype C: relevance for HIV pathogenesis and therapeutic intervention | |
| Jacobs | HIV-1 resistance analyses from therapy-naïve patients in South Africa, Tanzania and the characterization of a new HIV-1 subtype C proviral molecular clone | |
| Garcia Diaz | An Investigation of the role of HIV-1 Gag mutation in failure of Protease Inhibitors | |
| Venner | HIV-1 Group M Subtype Fitness, Disease Progression, and Entry Efficiency | |
| Nguyen | Ultra-deep sequencing applications in virology research | |
| 魏雅稚 | Analysis of HIV-1 co-receptor usage by cell fusion based assay using cloned full-length envelope | |
| Lisovsky | Emergence of Nelfinavir and Lopinavir resistance relative to a clinically relevant human immunodeficiency virus type-1 single nucleotide polymorphism at position 36 in protease enzyme «in vitro» | |
| Lau | Biology and Molecular Biology of New HIV-1 Recombinants from Malaysia | |
| Clevestig | HIV-1 phenotype and genetic variation in vertical transmission | |
| Clark | Distinct Mechanisms of HIV-1 Hypersusceptibility to Non-Nucleoside Reverse Transcriptase Inhibitors: A Discussion of Nucleoside Reverse Transcriptase Inhibitor Induced Mutations V118I, H208Y, and T215Y |